Moreover, there are OI patients presenting mutations in specific genes that directly affect the bone mineralization process such as IFITM5 (Interferon induced Transmembrane Protein 5) [115] and SERPINF1 (Serpin Family F Member 1) [116]. Here, IFITM5 is linked to osteogenesis imperfecta.